Logo

Talis Biomedical: Jeryl Hilleman

Mar 18, 2021

Point-of-care infectious disease firm Talis Biomedical has appointed Jeryl Hilleman to its board of directors, where she will serve as the chair of the audit committee. Currently, she serves as chairman of the board of Omada Health and is a director of Novocure, SI-Bone, and Minerva Neurosciences. Previously, Hilleman was CFO at multiple publicly traded companies, including Intersect ENT, Ocera Therapeutics, Amyris, Symyx Technologies, and Cytel.

Breaking News
The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to qualitative interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.